BILATERAL SALPINGECTOMY IN WOMEN UNDERGOING VAGINAL HYSTERECTOMY: TO DO OR NOT TO DO?
Department of Obstetrics and Gynecology, Faculty Of Medicine, Benha University, Egypt.
Aim: The objective of this study was to determine whether bilateral opportunistic salpingectomy (BOS) in women has detrimental effect on ovarian function and if this increases surgical complications with vaginal hysterectomy (VH) Patients and Methods: This prospective, open-label, randomized, parallel group was conducted at Benha University Hospital (BUH), and private center in El-Qalubia, Egypt, From September 2015 to March 2018. 110 women undergoing VH were allocated to adding BOS (intervention group) or not (control group) at 1 : 1 ratio. The primary outcome was difference in change of serum Anti-müllerian hormone (AMH), serum follicular stimulating hormone (FSH), antral follicular count (AFC), flow index (FI) vascularization index (VI), vascularization flow index (VFI) and calculated ovarian age (OvAge), measured preoperatively and at 3 to 6 months postoperatively. The secondary outcomes were surgical outcomes and hospital stay. Results: Baseline demographic, clinical, hormonal and three-dimensional ultrasonic criteria did not show significant difference between both groups. Also, the groups did not differ significantly regarding operative outcomes. Conclusion: Performing bilateral opportunistic salpingectomy at time of vaginal hysterectomy did not have a detrimental effect on ovarian function as well as surgical complications when compared with a policy of performing hysterectomy alone. So adding BOS as ovarian cancer risk-reducing surgery appears to be a safe procedure.